Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels.
about
Surgical strategy for the treatment of medullary thyroid carcinoma.Prognostic indicators in differentiated thyroid carcinoma.Medullary carcinoma of the thyroid.A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo.Update on thyroid cancer treatment.The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management.Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.The Ki67 index a prognostic marker in medullary thyroid carcinoma.The relevance of somatostatin receptors in thyroid neoplasia2012 European thyroid association guidelines for metastatic medullary thyroid cancer.Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.Calcitonin stimulation tests for the early diagnosis and follow-up of patients with C cell disease: a descriptive analysis.Unusual clinical manifestation of pheochromocytoma in a MEN2A patient.Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
P2860
Q33773265-8FB276A9-1D43-4D33-87A6-A9034B4D76ADQ33930365-86B3F063-C2BF-4D60-88CA-10ED4351410BQ33930380-32C1AD67-0D42-4D27-998D-B1AB5B34A29CQ34153520-912A43D2-1FC7-44B2-8177-A8CBC6958A66Q34310219-75D8ED12-02F0-4CE6-A40B-43AB55F9C638Q34444307-294A0E4F-E06C-407F-B370-29F8BFA6CFC8Q35396089-EA5044BA-CCB7-4510-BB0D-0594003EF821Q36648141-DE84AF73-DDD8-4248-AFCC-E90D41DAD212Q36988027-22E8A57C-6FE0-4A5E-A45D-D1B9601F42A2Q37290840-AB3A61A4-A050-4C96-AEE3-840785862E70Q39668289-653C4536-61C3-4F90-B502-087372981BFAQ42099722-198518F7-3590-4FB1-AECE-58ED3BDA88D7Q42518377-7ED8DFBE-BAF2-44DF-B6F0-0A20C4D32BBFQ44259563-BCAEE59D-437A-4620-8FE9-21C202DA45E7
P2860
Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Progression of postoperative r ...... d by plasma calcitonin levels.
@en
Progression of postoperative r ...... d by plasma calcitonin levels.
@nl
type
label
Progression of postoperative r ...... d by plasma calcitonin levels.
@en
Progression of postoperative r ...... d by plasma calcitonin levels.
@nl
prefLabel
Progression of postoperative r ...... d by plasma calcitonin levels.
@en
Progression of postoperative r ...... d by plasma calcitonin levels.
@nl
P2093
P1433
P1476
Progression of postoperative r ...... d by plasma calcitonin levels.
@en
P2093
P356
10.1016/S0039-6060(96)80210-8
P407
P577
1996-01-01T00:00:00Z